about
Non-Alcoholic Fatty Liver Disease and Metabolic Syndrome after Liver TransplantUpdate on Alcohol and Viral HepatitisTreatment of nonalcoholic steatohepatitis in adults: present and futureCharacterization of mutations in ATP8B1 associated with hereditary cholestasisHormonal therapy with megestrol in inoperable hepatocellular carcinoma characterized by variant oestrogen receptorsOvarian senescence increases liver fibrosis in humans and zebrafish with steatosis.Focal adhesion kinase depletion reduces human hepatocellular carcinoma growth by repressing enhancer of zeste homolog 2.Natural history of chronic HBV infection: special emphasis on the prognostic implications of the inactive carrier state versus chronic hepatitis.Boceprevir is highly effective in treatment-experienced hepatitis C virus-positive genotype-1 menopausal women.Estrogens receptors and oxidative damage in the liver.Experimental hepatology applied to stem cells.Translating pharmacogenetics into clinical practice: interleukin (IL)28B and inosine triphosphatase (ITPA) polymophisms in hepatitis C virus (HCV) infection.Acute hepatitis B caused by a vaccine-escape HBV strain in vaccinated subject: sequence analysis and therapeutic strategy.Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study.Interleukin 28B polymorphisms as predictors of sustained virological response in chronic hepatitis C: systematic review and meta-analysis.Microenvironment inflammatory infiltrate drives growth speed and outcome of hepatocellular carcinoma: a prospective clinical study.Non-alcoholic steatohepatitis and liver transplantation.Biology of Hepatocellular Carcinoma.Modelling cost-effectiveness and health gains of a "universal" vs. "prioritized" HCV treatment policy in a real-life cohort.Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients.Histone deacetylase 4 promotes cholestatic liver injury in the absence of prohibitin-1Fine-resolution mapping by haplotype evaluation: the examples of PFIC1 and BRIC.Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.Interferon lambda-3 is not associated with clinical outcome in patients with HCV-induced compensated cirrhosis: a long-term cohort study.The role played by gender in viral hepatitis.Alpha but not beta interferon is useful in chronic active hepatitis due to hepatitis C virus. A prospective, double-blind, randomized study.Hepatitis C virus testing in primary biliary cirrhosis.HCV RNA in serum of asymptomatic blood donors involved in post-transfusion hepatitis (PTH).Lack of association between circulating HCV-RNA and anti-HCV positivity in primary biliary cirrhosis.Antibodies to hepatitis C virus in patients with hepatocellular carcinoma.Retrospective, observational, multicentre study on an Italian population affected by chronic hepatitis C who failed to clear HCV-RNA after the combined therapy (PEG-IFN and ribavirin): NADIR study.Interleukin-1β, C-x-C motif ligand 10, and interferon-gamma serum levels in mixed cryoglobulinemia with or without autoimmune thyroiditis.Early menopause is associated with lack of response to antiviral therapy in women with chronic hepatitis C.Evidence for hepatitis B virus infection in patients with chronic hepatitis C with and without serological markers of hepatitis B.Reactivation of hepatitis B virus infection induced by interferon (IFN) in HBsAg-positive, antiHCV-positive patients.Pretreatment with pegylated interferon prevents emergence of lamivudine mutants in lamivudine-naive patients: a pilot study.Effect of ursodeoxycholic acid treatment on alanine aminotransferase and gamma-glutamyltranspeptidase serum levels in patients with hypertransaminasemia. Results from a double-blind controlled trial.Ten-year combination treatment with colchicine and ursodeoxycholic acid for primary biliary cirrhosis: a double-blind, placebo-controlled trial on symptomatic patients.Cimetidine administration and tubular creatinine secretion in patients with compensated cirrhosis.Orthogonal polarization spectral imaging: a new tool in morphologic surveillance in intestinal transplant recipients.
P50
Q26751404-8099D39E-5928-4DB7-9920-6C2C757BCB70Q26781897-3A0D30F2-49A8-472E-BDD1-ABE4973F9ADEQ26852403-E3BE5601-1080-484E-977B-D610A419EA71Q28270588-72EF5379-2FB2-4969-BCD7-C0A14BAFA8FBQ28361945-46680D20-3A3C-45AC-AD55-7DA4CA3AB1E2Q30402192-F6CB6666-FD8F-4820-84BF-98F1A848FAD3Q33652164-3230D9EE-FAA6-4393-A9CB-C6078BB942D9Q34157099-202F072F-3C0D-42C5-9747-AD4D47B31851Q34589830-75268958-018B-4F4D-9B57-2766C94C72A2Q34772506-33FB3F4C-9AE2-4980-8DC0-9BB24B4FDF82Q36998753-F99C88FD-53C5-4BCE-81B3-36A8207767CEQ37879701-6900A163-1BD1-4EBE-9BC4-508EA0AC964AQ38301330-6F35DCA5-0EA7-4189-BDF4-1B2339E319A1Q38416518-F4B15443-B75F-4279-984E-6F65A214E298Q38445623-076A6994-9A3F-47EB-940A-A35AEA515B7BQ38610336-8A4E9DF4-AC41-4E66-955C-08FE5D8FD68DQ38796432-DD09E08C-39D7-413A-8A93-CD5A7EBDDA1EQ38961036-26B25BAB-714F-4622-95B8-A6D7EF3BBCE6Q40121053-40CEDCC5-C166-46C3-98DE-DEEE561C1FD6Q40619369-864090E9-4082-4564-A78D-96ADFB433F81Q40799410-B5787621-6B55-44CF-A4C0-72283DF53CD5Q41664154-9AF49309-F8D3-415E-BE16-4B1C7B6C0504Q41669067-5837530D-58E8-4E05-A1BC-A9956C2ACA33Q41759513-0CF997BE-DB47-4462-B8F5-F5F1A9401E0FQ42202432-1ECAC045-77CB-4A73-9006-7C83094772F9Q42977220-04169559-CB51-4D1E-B27F-C3A5D7A36D7DQ42981793-AD35AA16-2151-42F9-96F3-B58D9962B974Q42984953-94F50494-7363-4D5A-A099-8A14B614107CQ42985326-0CCA7AB3-D44C-4275-9852-C8A6204E05E2Q42986538-5E962B25-7869-4734-9650-25FD41CB0739Q42991285-A788B497-015C-4A4A-B311-FF53AAA313EAQ43000467-11355FA8-4AAD-4C8E-995E-41931CBD879BQ43032172-5B86DE67-03FA-4FB9-9A47-CE55752B5E95Q43036536-41040B69-8125-472C-A768-45D66B68CEB4Q43038806-D95B90D3-4375-4103-AB32-A93C2663182DQ43208923-073ABC72-7254-4CE7-A79B-9ABF0DA5BDB7Q43723518-87544C9D-3AAB-484C-9D65-9EB56171C9E6Q43734578-7C277A4F-5A77-4D5A-9107-3F41BA8C0A9CQ43827751-553E603C-A4F3-4B1C-9CA9-509D6662B6E3Q44008917-CDF78474-AEBE-499A-B766-A129FA4CEB2A
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Erica Villa
@ast
Erica Villa
@en
Erica Villa
@es
Erica Villa
@nl
Erica Villa
@sl
type
label
Erica Villa
@ast
Erica Villa
@en
Erica Villa
@es
Erica Villa
@nl
Erica Villa
@sl
prefLabel
Erica Villa
@ast
Erica Villa
@en
Erica Villa
@es
Erica Villa
@nl
Erica Villa
@sl
P1053
A-7576-2012
P106
P21
P31
P3829
P496
0000-0001-6388-7022